[ sulge aken ]

Elulookirjeldus (CV)
1.Eesnimi Tiiu
2.Perekonnanimi Aareleid
3.Töökoht a) Tervise Arengu Instituut (TAI), epidemioloogia ja biostatistika osakond; b) SA Põhja-Eesti Regionaalhaigla onkoloogiakeskus(SA PER), Eesti Vähiregister
4.Ametikoht a) vanemteadur; b) juhataja
5.Sünniaeg 03.11.1946 (päev.kuu.aasta)
6.Haridus kõrgem,Tartu Riiklik Ülikool, 1971
7.Teenistuskäik Tartu Vabariiklik Kliiniline Haigla, arst-intern(1971-1972), arst (1972-1974); Tervishoiu Ministeeriumi Arvutuskeskus, töörühma juht (1974-1978), juhataja asetäitja (1978-1979); EKMI (praegu:TAI), nooremteadur (1979-1990), vanemteadur (1990-1996), vanemteadur kohakaasluse alusel (1996-); Eesti Onkoloogiaskeskus (praegu: SA PER Onkoloogiakeskus), Eesti Vähiregistri juhataja (1996-)
8.Teaduskraad med. kand. (onkoloogia)
9.Teaduskraadi välja
andnud asutus, aasta
Üleliiduline Onkoloogiakeskus, Moskva, 1988
10.Tunnustused Eesti Vabariigi teaduspreemia meditsiini alal (1997); EKMI teaduspreemia (1996); TAI teaduspreemiad (2002, 2005); TAI diplom teaduspublikatsioonide eest(2004)
11.Teadusorganisatsiooniline
ja –administratiivne
tegevus
Rahvusvaheline Vähiregistrite Assotsiatsioon (IACR), juhatuse liige (2000-2003) ja Calum Muir'i stipendiumikomisjoni liige (2003); TAI teadusnõukogu liige (2005-)
12.Juhendamisel kaitstud
väitekirjad
13.Teadustöö põhisuunad vähi registreerimine ja statistika, kirjeldav vähiepidemioloogia, elulemuse hindamine
14.Jooksvad grandid a) ETFi grant nr6027 "Munandivähk Eestis: kirjeldav epidemioloogia ja ravitulemuste parandamine" (TAI, 2005-2007, vastutav täitja (grandihoidja);
b) EV Haridus- ja teadus-ministeeriumi grant nr 0192112s02: sihtfinantseeritav teadusteema "Haiguste esinemine, nende mõjurid ja molekulaarsed markerid Eesti rahvastikus" (TAI, 2002-2006,vastutav täitja prof. M. Rahu), põhitäitja
15.Teaduspublikatsioonid

Tyczynski JE, Bray F, Aareleid T, Dalmas M, Kurtinaitis J, Plesko I, Pompe-Kirn V, Stengrevics A, Parkin DM. Lung cancer mortality patterns in selected central, eastern and southern European countries. Int J Cancer 2004;109:598-610.

Lang K, Mägi M, Aareleid T. Study of completeness of registration at the Estonian cancer registry. Eur J Cancer Prev 2003;12:153–6.

Moller T, Anderson H, Aareleid T, Hakulinen T, Storm H, Truggvadottir L, Corazziari I, Mugno E and EUROPREVAL Working Group. Cancer prevalence in Northern Europe: the EUROPREVAL study. Ann Oncol 2003;14:946–57.

Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, Grosclaude P, Hédelin G, Matsuda T, Møller H, Möller T, Verdecchia A, Capocaccia R, Gatta G, Micheli A, Santaquilani M, Roazzi P, Lisi D, the EUROCARE Working Group. EUROCARE-3: survival of cancer patients diagnosed 1990–94 – results and commentary. Ann Oncol 2003;14:v61–v118.

Aareleid T, Brenner H. Trends in cancer patient survival in Estonia before and after the transition from a Soviet republic to an open-market economy. Int J Cancer 2002;102:45–50.

viimati muudetud: 06.10.2005

Curriculum Vitae (CV)
1.First Name Tiiu
2.Surname Aareleid
3.Institution a) National Institute for Health Development (NIHD); b) North Estonian Regional Hospital Foundation's Cancer Centre
4.Position a) Senior Researcher; b) Director of Estonian Cancer Registry
5.Date of birth 03.11.1946 (day.month.year)
6.Education higher, University of Tartu, 1971
7.Research and
professional experience
Tartu University Hospital - Internist (1971-1972), Physician (1972-1974); Data Processing Centre of Ministry of Health - Head of Unit (1974-1978), Deputy Director (1978-1979); Institute of Experimental and Clinical Medicine (now: NIHD) - Junior Researcher (1979-1990), Senior Researcher 1990-; simultaneously affiliated with Estonian Cancer Centre (now: North Estonian Regional Hospital Foundation's Cancer Centre) - Director of Estonian Cancer Registry (1996-)
8.Academic degree Ph.D. (Cand. Med. in Oncology)
9.Dates and sites of
earning the degrees
USSR Cancer Research Centre, Moscow, 1988
10.Honours/awards Annual National Science Award in Medicine (1997); Annual Research Award of Institute of Experimental and Clinical Medicine (1996); Annual Research Award of National Institute for Health Development (NIHD) (2002, 2005); Diploma of NIHD for scientifc publications (2004)
11.Research-administrative
experience
International Association of Cancer Registries (IACR), Member of Executive Committee (2000-2003) and Calum Muir Fellowship Committee (2003); Member of Scientific Council of NIHD (2005-)
12.Supervised dissertations
13.Current research program cancer registration and statistics, descriptive epidemiology, survival studies
14.Current grant funding a) Estonian Science Foundation, grant No 6027 "Testicular cancer in Estonia: descriptive epidemiology and improvement of outcomes" (NIHD, 2005-2007) - principal investigator (grant holder);

b) Ministry of Education and Science of Estonia, target funding grant No 0192112s02 "Occurrence of Diseases, their determinants and molecular markers" (NIHD, 2002-2006; project leader - Prof. M. Rahu)- main investigator
15.List of most important publications

Tyczynski JE, Bray F, Aareleid T, Dalmas M, Kurtinaitis J, Plesko I, Pompe-Kirn V, Stengrevics A, Parkin DM. Lung cancer mortality patterns in selected central, eastern and southern European countries. Int J Cancer 2004;109:598-610.

Lang K, Mägi M, Aareleid T. Study of completeness of registration at the Estonian cancer registry. Eur J Cancer Prev 2003;12:153–6.

Moller T, Anderson H, Aareleid T, Hakulinen T, Storm H, Truggvadottir L, Corazziari I, Mugno E and EUROPREVAL Working Group. Cancer prevalence in Northern Europe: the EUROPREVAL study. Ann Oncol 2003;14:946–57.

Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, Grosclaude P, Hédelin G, Matsuda T, Møller H, Möller T, Verdecchia A, Capocaccia R, Gatta G, Micheli A, Santaquilani M, Roazzi P, Lisi D, the EUROCARE Working Group. EUROCARE-3: survival of cancer patients diagnosed 1990–94 – results and commentary. Ann Oncol 2003;14:v61–v118.

Aareleid T, Brenner H. Trends in cancer patient survival in Estonia before and after the transition from a Soviet republic to an open-market economy. Int J Cancer 2002;102:45–50.

last updated: 06.10.2005

[ sulge aken ]